Implementation of new antithrombotic treatment strategies and outcome improvements in patients with myocardial infarction and atrial fibrillation over 20 years: a nationwide cohort study

29 August 2025 (12:00 - 12:12)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Christian Losciale

Nykopings Lasarett, Nykoping (Sweden)

4 More presentations in this session

Presentation thumbnail

Prognostic value of excess apolipoprotein B in coronayr artery disease: a pooled analysis of nationwide cohorts

Doctor X. Lu (Guangzhou, CN)

Abstract Slides Video

Presentation thumbnail

Prevalence of elevated lipoprotein(a) in premature ASCVD patients and its association with major adverse cardiovascular events: analysis of a large US electronic health record database

Doctor N. Shah (Cary, US)

Abstract Slides Video

Presentation thumbnail

PROGNosis in Obstructive Sleep Apnea after Myocardial Infarction - the PROGNOSA-MI study

Mr M. Olszowka (Uppsala, SE)

Abstract Slides Video

Presentation thumbnail

Regional and demographic variations in diabetes mellitus and myocardial infarction mortality among US adults: a retrospective observational analysis from 1999-2023

Doctor C. Ranasinghe (Birmingham, GB)

Abstract Slides Video

Access the full session

Session thumbnail

Comorbidities and prognosis in chronic coronary syndromes

The Event

Event poster

ESC Congress 2025

29 August 2025 12:00 CET

You may be interested in

Congress Presentation

Temporal trends in initiation of oral anticoagulants and stroke-free survival among elderly and very elderly patients with new onset atrial fibrillation - a 20-year perspective.

Congress Session

Improving prognostication in chronic coronary syndromes

Congress Session

Stroke risk management in atrial fibrillation registries: key take-home messages for clinicians

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources